$314.51
0.700.22%
At close: -
$314.51
0.000.00%
After Hours: Apr 25, 4:05 PM EDT
Comments
Loading...
Molina Healthcare Analyst Ratings and Price Targets | NYSE:MOH | Benzinga
Molina Healthcare Inc has a consensus price target of $371 based on the ratings of 24 analysts. The high is $439 issued by B of A Securities on April 1, 2024. The low is $297 issued by Jefferies on July 24, 2024. The 3 most-recent analyst ratings were released by Barclays, Bernstein, and Baird on April 25, 2025, April 22, 2025, and April 15, 2025, respectively. With an average price target of $383.67 between Barclays, Bernstein, and Baird, there's an implied 21.99% upside for Molina Healthcare Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Bernstein
Baird
Truist Securities
Mizuho
1calculated from analyst ratings
Analyst Ratings for Molina Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/25/2025 | Buy Now | 15.1% | Barclays | Andrew Mok54% | $339 → $362 | Maintains | Equal-Weight | Get Alert |
| 04/22/2025 | Buy Now | 31.63% | Bernstein | Lance Wilkes66% | → $414 | Initiates | → Outperform | Get Alert |
| 04/15/2025 | Buy Now | 19.23% | Baird | Michael Ha50% | $331 → $375 | Downgrade | Outperform → Neutral | Get Alert |
| 04/11/2025 | Buy Now | 27.18% | Truist Securities | David Macdonald64% | $340 → $400 | Maintains | Buy | Get Alert |
| 04/09/2025 | Buy Now | — | Guggenheim | Jason Cassorla48% | — | Initiates | → Neutral | Get Alert |
| 04/09/2025 | Buy Now | 27.18% | Mizuho | Ann Hynes85% | $376 → $400 | Maintains | Outperform | Get Alert |
| 03/05/2025 | Buy Now | 18.28% | Wells Fargo | Stephen Baxter55% | $295 → $372 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/03/2025 | Buy Now | 19.55% | Mizuho | Ann Hynes85% | $382 → $376 | Maintains | Outperform | Get Alert |
| 02/19/2025 | Buy Now | 8.1% | Truist Securities | David Macdonald64% | $370 → $340 | Maintains | Buy | Get Alert |
| 02/07/2025 | Buy Now | 7.79% | Barclays | Andrew Mok54% | $372 → $339 | Maintains | Equal-Weight | Get Alert |
| 02/07/2025 | Buy Now | 3.34% | UBS | Kevin Caliendo71% | $330 → $305 | Maintains | Neutral | Get Alert |
| 02/06/2025 | Buy Now | 9.69% | Stephens & Co. | Raj Kumar 49% | $345 → $345 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 01/06/2025 | Buy Now | 17.64% | Truist Securities | David Macdonald64% | $400 → $370 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | 11.28% | JP Morgan | John Stansel68% | $378 → $350 | Assumes | Overweight → Neutral | Get Alert |
| 11/04/2024 | Buy Now | 15.1% | Wells Fargo | Stephen Baxter55% | $360 → $362 | Maintains | Equal-Weight | Get Alert |
| 10/25/2024 | Buy Now | 18.28% | Barclays | Andrew Mok54% | $359 → $372 | Maintains | Equal-Weight | Get Alert |
| 10/24/2024 | Buy Now | 29.09% | Cantor Fitzgerald | Sarah James50% | $406 → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 10/24/2024 | Buy Now | 5.24% | Baird | Michael Ha50% | $405 → $331 | Maintains | Outperform | Get Alert |
| 10/01/2024 | Buy Now | 29.09% | Cantor Fitzgerald | Sarah James50% | $406 → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 09/10/2024 | Buy Now | 29.09% | Cantor Fitzgerald | Sarah James50% | $406 → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | 29.09% | Cantor Fitzgerald | Sarah James50% | $406 → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 08/05/2024 | Buy Now | 14.46% | Wells Fargo | Stephen Baxter55% | $315 → $360 | Maintains | Equal-Weight | Get Alert |
| 07/29/2024 | Buy Now | 12.24% | Deutsche Bank | George Hill62% | $354 → $353 | Maintains | Hold | Get Alert |
| 07/29/2024 | Buy Now | 20.19% | TD Cowen | Gary Taylor60% | $351 → $378 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 1.75% | Stephens & Co. | Scott Fidel69% | $320 → $320 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/25/2024 | Buy Now | 29.09% | Cantor Fitzgerald | Sarah James50% | $406 → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2024 | Buy Now | 11.6% | TD Cowen | Gary Taylor60% | $412 → $351 | Maintains | Buy | Get Alert |
| 07/24/2024 | Buy Now | -5.57% | Jefferies | David Windley75% | $354 → $297 | Maintains | Hold | Get Alert |
| 07/23/2024 | Buy Now | 29.09% | Cantor Fitzgerald | Sarah James50% | $406 → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | Buy Now | 0.16% | Wells Fargo | Stephen Baxter55% | $375 → $315 | Maintains | Equal-Weight | Get Alert |
| 07/15/2024 | Buy Now | 27.18% | Truist Securities | David Macdonald64% | $440 → $400 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 25.59% | JP Morgan | Lisa Gill59% | $420 → $395 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | 33.54% | JP Morgan | Lisa Gill59% | $435 → $420 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | 28.77% | Baird | Michael Ha50% | → $405 | Initiates | → Outperform | Get Alert |
| 04/30/2024 | Buy Now | 31% | TD Cowen | Gary Taylor60% | $453 → $412 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | 19.23% | Wells Fargo | Stephen Baxter55% | $410 → $375 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | 24% | Stephens & Co. | Scott Fidel69% | $390 → $390 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | 36.72% | Barclays | Andrew Mok54% | $437 → $430 | Maintains | Equal-Weight | Get Alert |
| 04/15/2024 | Buy Now | 30.36% | Wells Fargo | Stephen Baxter55% | $440 → $410 | Maintains | Equal-Weight | Get Alert |
| 04/04/2024 | Buy Now | 29.09% | Cantor Fitzgerald | Sarah James50% | $406 → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | Buy Now | 39.58% | B of A Securities | Kevin Fischbeck68% | → $439 | Downgrade | Neutral → Underperform | Get Alert |
| 03/28/2024 | Buy Now | 39.58% | B of A Securities | Kevin Fischbeck68% | → $439 | Downgrade | Neutral → Underperform | Get Alert |
| 03/20/2024 | Buy Now | 39.9% | Wells Fargo | Stephen Baxter55% | $420 → $440 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | 38.95% | Barclays | Andrew Mok54% | → $437 | Initiates | → Equal-Weight | Get Alert |
| 02/20/2024 | Buy Now | 46.26% | Truist Securities | David Macdonald64% | $435 → $460 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 33.54% | Wells Fargo | Stephen Baxter55% | $367 → $420 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 02/09/2024 | Buy Now | 29.09% | Cantor Fitzgerald | Sarah James50% | $374 → $406 | Maintains | Overweight | Get Alert |
| 12/21/2023 | Buy Now | 20.82% | UBS | Kevin Caliendo71% | $350 → $380 | Maintains | Neutral | Get Alert |
| 11/21/2023 | Buy Now | 18.92% | Cantor Fitzgerald | Sarah James50% | → $374 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | Buy Now | 24.64% | JP Morgan | Calvin Sternick47% | $367 → $392 | Maintains | Overweight | Get Alert |
| 10/03/2023 | Buy Now | 11.28% | Stephens & Co. | Scott Fidel69% | → $350 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 09/14/2023 | Buy Now | 14.15% | Cantor Fitzgerald | Sarah James50% | → $359 | Reiterates | Overweight → Overweight | Get Alert |
| 07/14/2023 | Buy Now | 16.05% | Morgan Stanley | Ricky Goldwasser79% | $365 → $365 | Reiterates | Overweight → Overweight | Get Alert |
| 07/07/2023 | Buy Now | 8.42% | JP Morgan | Calvin Sternick47% | $348 → $341 | Maintains | Overweight | Get Alert |
| 06/20/2023 | Buy Now | 16.05% | Truist Securities | David Macdonald64% | $380 → $365 | Maintains | Buy | Get Alert |
| 06/20/2023 | Buy Now | -1.43% | UBS | Kevin Caliendo71% | → $310 | Initiates | → Neutral | Get Alert |
| 05/08/2023 | Buy Now | 6.51% | Deutsche Bank | George Hill62% | $365 → $335 | Maintains | Hold | Get Alert |
| 05/03/2023 | Buy Now | 10.97% | TD Cowen | Gary Taylor60% | $380 → $349 | Maintains | Outperform | Get Alert |
| 05/01/2023 | Buy Now | 16.05% | Deutsche Bank | George Hill62% | $356 → $365 | Maintains | Hold | Get Alert |
| 04/28/2023 | Buy Now | 11.28% | Credit Suisse | Jonathan Yong65% | $347 → $350 | Maintains | Outperform | Get Alert |
| 04/28/2023 | Buy Now | -7.79% | Wells Fargo | Stephen Baxter55% | $282 → $290 | Maintains | Underweight | Get Alert |
| 04/27/2023 | Buy Now | 11.28% | Stephens & Co. | Scott Fidel69% | → $350 | Reiterates | → Equal-Weight | Get Alert |
| 04/21/2023 | Buy Now | 12.56% | Cantor Fitzgerald | Sarah James50% | → $354 | Initiates | → Overweight | Get Alert |
| 03/21/2023 | Buy Now | -10.34% | Wells Fargo | Stephen Baxter55% | $307 → $282 | Maintains | Underweight | Get Alert |
| 02/23/2023 | Buy Now | 10.65% | JP Morgan | Calvin Sternick47% | $360 → $348 | Maintains | Overweight | Get Alert |
| 02/17/2023 | Buy Now | -2.39% | Wells Fargo | Stephen Baxter55% | $340 → $307 | Maintains | Underweight | Get Alert |
| 02/10/2023 | Buy Now | 20.82% | Truist Securities | David Macdonald64% | $400 → $380 | Maintains | Buy | Get Alert |
| 02/10/2023 | Buy Now | 10.33% | Credit Suisse | Jonathan Yong65% | $395 → $347 | Maintains | Outperform | Get Alert |
| 02/09/2023 | Buy Now | 19.23% | Stephens & Co. | Scott Fidel69% | → $375 | Maintains | Equal-Weight | Get Alert |
| 01/04/2023 | Buy Now | 19.23% | Barclays | Steve Valiquette54% | $400 → $375 | Maintains | Overweight | Get Alert |
| 01/03/2023 | Buy Now | 8.1% | Wells Fargo | Stephen Baxter55% | $345 → $340 | Maintains | Underweight | Get Alert |
| 12/13/2022 | Buy Now | 23.37% | B of A Securities | Kevin Fischbeck68% | → $388 | Upgrade | Underperform → Neutral | Get Alert |
| 11/01/2022 | Buy Now | 12.87% | Deutsche Bank | George Hill62% | $315 → $355 | Maintains | Hold | Get Alert |
| 10/28/2022 | Buy Now | 27.18% | Barclays | Steven Valiquette58% | $380 → $400 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 33.54% | Truist Securities | David Macdonald64% | $390 → $420 | Maintains | Buy | Get Alert |
| 10/27/2022 | Buy Now | 30.36% | Credit Suisse | A.J. Rice69% | $350 → $410 | Maintains | Outperform | Get Alert |
| 10/03/2022 | Buy Now | 14.46% | JP Morgan | Calvin Sternick47% | → $360 | Initiates | → Overweight | Get Alert |
| 08/26/2022 | Buy Now | 9.69% | Wells Fargo | Stephen Baxter55% | $307 → $345 | Maintains | Underweight | Get Alert |
| 07/29/2022 | Buy Now | 16.37% | Mizuho | Ann Hynes85% | $345 → $366 | Maintains | Buy | Get Alert |
| 07/29/2022 | Buy Now | 20.82% | Barclays | Steve Valiquette54% | $340 → $380 | Maintains | Overweight | Get Alert |
| 06/17/2022 | Buy Now | -1.43% | Loop Capital | Joseph France66% | → $310 | Initiates | → Hold | Get Alert |
| 05/26/2022 | Buy Now | 6.51% | B of A Securities | Kevin Fischbeck68% | $355 → $335 | Downgrade | Buy → Underperform | Get Alert |
| 05/25/2022 | Buy Now | -4.3% | Wells Fargo | Stephen Baxter55% | $308 → $301 | Maintains | Underweight | Get Alert |
| 05/02/2022 | Buy Now | -1.12% | Deutsche Bank | George Hill62% | $308 → $311 | Maintains | Hold | Get Alert |
FAQ
What is the target price for Molina Healthcare (MOH) stock?
The latest price target for Molina Healthcare (NYSE:MOH) was reported by Barclays on April 25, 2025. The analyst firm set a price target for $362.00 expecting MOH to rise to within 12 months (a possible 15.10% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Molina Healthcare (MOH)?
The latest analyst rating for Molina Healthcare (NYSE:MOH) was provided by Barclays, and Molina Healthcare maintained their equal-weight rating.
When was the last upgrade for Molina Healthcare (MOH)?
The last upgrade for Molina Healthcare Inc happened on March 5, 2025 when Wells Fargo raised their price target to $372. Wells Fargo previously had an equal-weight for Molina Healthcare Inc.
When was the last downgrade for Molina Healthcare (MOH)?
The last downgrade for Molina Healthcare Inc happened on April 15, 2025 when Baird changed their price target from $331 to $375 for Molina Healthcare Inc.
When is the next analyst rating going to be posted or updated for Molina Healthcare (MOH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Molina Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Molina Healthcare was filed on April 25, 2025 so you should expect the next rating to be made available sometime around April 25, 2026.
Is the Analyst Rating Molina Healthcare (MOH) correct?
While ratings are subjective and will change, the latest Molina Healthcare (MOH) rating was a maintained with a price target of $339.00 to $362.00. The current price Molina Healthcare (MOH) is trading at is $314.51, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
